Hebei Guolong Pharmaceutical Co., Ltd. was established in 2011 and is located in Liangcun Economic and Technological Development Zone, Shijiazhuang City, Hebei Province, and is a wholly-owned subsidiary of Shijiazhuang No. 4 Pharmaceutical Group. It is a professional API production enterprise established and developed by the group to actively promote the development strategy of "API + preparation", make full use of the advantages of the whole industry chain, adhere to the concept of "green pharmaceutical", introduce advanced equipment and green technology at home and abroad. 

Guolong Pharmaceutical adheres to the business direction of coordinated development of innovative and characteristic APIs based on bulk APIs, increases investment in scientific research and development, and promotes the international layout of APIs. Mainly produces bulk API azithromycin and its intermediates, hydroxyethyl starch 40, hydroxyethyl starch 130/0.4 and other hydroxyethyl starch series, moxifloxacin hydrochloride, arbidol hydrochloride, and bromhexine hydrochloride and other characteristic API products. It can produce 500 tons of hydroxyethyl starch series and 500 tons of azithromycin annually, and its domestic sales level is in the forefront within the same industry.

Hebei Guolong Pharmaceutical Co., Ltd. has strong advantages and outstanding characteristics in the industry in terms of green, innovation, digitalization, and high-end chemical drugs. We posses international standard production facilities and workshops, and has established and improved the quality management system in strict accordance with the new national GMP standards, and the technical indicators of our products have always been in the forefront of the domestic industry. At present, the company has successively passed a number of domestic and foreign certifications such as Kosher and new GMP, adhering to the business philosophy of "love the people with quality, formed the base with integrity", and is committed to developing the domestic high-end market and the international market.